Metraipolis › archive › dc_4f41409fd050
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal… — Europe PMC PMID:41041325
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41041325
- DOI
- 10.3389/fimmu.2025.1633532
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:59:19.337Z
- SHA-256 of the archived text
a106c1b9a5bcffbfb69f94986f276606330f9b0c44ac66bde24b06e335da13f8- Stable URL of this page
https://metraipolis.com/documento/dc_4f41409fd050
How to cite
B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal… — Europe PMC PMID:41041325 — Europe PMC (en), https://europepmc.org/article/MED/41041325 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f41409fd050 (Metraipolis archive dc_4f41409fd050, sha256 a106c1b9a5bcffbfb69f94986f276606330f9b0c44ac66bde24b06e335da13f8)
BibTeX
@misc{dc4f41409fd050,
title = {B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal… — Europe PMC PMID:41041325},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41041325},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f41409fd050; sha256 a106c1b9a5bcffbfb69f94986f276606330f9b0c44ac66bde24b06e335da13f8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041325. Agents can read the archived copy with the MCP tool read_document.